'%2F%3E%3Cpath%20d%3D'M6.5%2025%2016%207%2025.5%2025'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'3.8'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Ccircle%20cx%3D'16'%20cy%3D'19'%20r%3D'3.2'%20fill%3D'%23fff'%2F%3E%3C%2Fsvg%3E){kind=small}
Gian Life Care Limited
GIANLIFE (BSE 542918) · ISIN INE063601012 · Healthcare Service Provider · Est. 2018 · listed 2020 · website
Not on any surveillance list
Quarterly results
No quarterly results stored for this company yet.
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 30 Sep 2025 standalone | ₹19.35 cr | ₹4.89 cr | ₹33.77 cr |
| 31 Mar 2025 standalone | ₹19.76 cr | ₹5.06 cr | ₹35.55 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 30.17% | — | — | 69.83% |
Latest filings
- Quarterly Results December 2025 14 February 2026 · BSE
- Pursuant to the provisions of Regulation 30 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, .... 14 February 2026 · BSE
- Dear Sir/ Maam, Please find attached herewith Unaudited Standalone and Consolidated Financial Results for the quarter/ half year ended September 30, 2025. Kindly take the same on .... 28 January 2026 · BSE
- Pursuant to the provisions of Regulation 30 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, .... 28 January 2026 · BSE
- Annual Report FY2024-25 (New) 10 September 2025 · BSE
Other companies in Healthcare Service Provider
- Dr. Lal Path Labs Ltd.
- Metropolis Healthcare Limited
- Thyrocare Technologies Limited
- Vijaya Diagnostic Centre Limited
- Krsnaa Diagnostics Limited
- One Global Service Provider Limited
- Nephrocare Health Services Limited
- Suraksha Diagnostic Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 29 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.